Karas Eric
Chief Commercial Officer
Sale 10b5-1
- Shares
- 25,000
- Price
- $10.00
- Value
- $250,000
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•29 filings
SPRY
ARS Pharmaceuticals, Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$1,949,747
4 distinct insiders
Highlighted alerts
3
6 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get SPRY insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
SPRY overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
40
Raw transactions
Everything returned by the filing
9
Voluntary view
P/S trades after deterministic checks
31
Administrative noise
Stored, never alerted
10
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 1,036,923
- Price
- $0.00
- Footnotes
- 1
25% of the shares subject to the option vest on July 7, 2027, and the remaining shares will vest monthly thereafter over three years.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Fitzpatrick Alexander A
Chief Legal Officer
Sale 10b5-1
- Shares
- 3,355
- Price
- $10.00
- Value
- $33,550
Dorsey Brian
Chief Operating Officer
SaleAlert
- Shares
- 21,828
- Price
- $8.71
- Value
- $190,050
Chakma Justin
Chief Business Officer
SaleAlert
- Shares
- 136,380
- Price
- $8.86
- Value
- $1,208,790
Chakma Justin
Chief Business Officer
SaleAlert
- Shares
- 30,000
- Price
- $8.91
- Value
- $267,357
Lowenthal Richard E
PRESIDENT AND CEO
Sale 10b5-1
- Shares
- 50,000
- Price
- $14.49
- Value
- $724,345
Scott Kathleen D.
Chief Financial Officer
Sale 10b5-1
- Shares
- 12,500
- Price
- $15.00
- Value
- $187,500
Tanimoto Sarina
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 37,656
- Price
- $14.09
- Value
- $530,626
Tanimoto Sarina
CHIEF MEDICAL OFFICER
Sale 10b5-1
- Shares
- 12,344
- Price
- $14.03
- Value
- $173,130
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Karas Eric Chief Commercial Officer | Sale | 25,000 | $10.00 | $250,000 | |
| Jun 12, 2026 | Fitzpatrick Alexander A Chief Legal Officer | Sale | 3,355 | $10.00 | $33,550 | |
| Nov 13, 2025 | Dorsey Brian Chief Operating Officer | Sale | 21,828 | $8.71 | $190,050 | |
| Nov 12, 2025 | Chakma Justin Chief Business Officer | Sale | 136,380 | $8.86 | $1,208,790 | |
| Nov 12, 2025 | Chakma Justin Chief Business Officer | Sale | 30,000 | $8.91 | $267,357 | |
| Aug 21, 2025 | Lowenthal Richard E PRESIDENT AND CEO | Sale | 50,000 | $14.49 | $724,345 | |
| Aug 21, 2025 | Scott Kathleen D. Chief Financial Officer | Sale | 12,500 | $15.00 | $187,500 | |
| Aug 20, 2025 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale | 37,656 | $14.09 | $530,626 | |
| Aug 19, 2025 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale | 12,344 | $14.03 | $173,130 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.